E2F1, the most investigated member of E2Fs, has been confirmed to have prognostic value in many tumors, such as hepatocellular carcinoma (35), breast cancer (36), and pancreatic ductal adenocarcinoma (37), and spinal osteosarcoma (38). Here, E2F1 is linked to pancreatic ductal adenocarcinoma.